# Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)

> **NCT01489384** · — · UNKNOWN · sponsor: **Pope Research Corporation** · enrollment: 125 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01489384
- **Lead sponsor:** Pope Research Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2018-08-27
- **Final completion:** 2018-09
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489384, "Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01489384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*